2014
DOI: 10.1016/j.fertnstert.2014.08.013
|View full text |Cite
|
Sign up to set email alerts
|

Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone–stratified, dose–response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection

Abstract: NCT01426386.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

12
117
4
6

Year Published

2015
2015
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 149 publications
(139 citation statements)
references
References 29 publications
12
117
4
6
Order By: Relevance
“…In this context, a recent study has been unable to find a linear relationship between FSH doses and the overall number of blastocysts or by AMH strata. Thus a threshold level may exist for starting the gonadotropin dose, and no more competent oocytes can be obtained if it is exceeded [12]. …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In this context, a recent study has been unable to find a linear relationship between FSH doses and the overall number of blastocysts or by AMH strata. Thus a threshold level may exist for starting the gonadotropin dose, and no more competent oocytes can be obtained if it is exceeded [12]. …”
Section: Discussionmentioning
confidence: 99%
“…It has been recently suggested that a threshold level for gonadotropin doses may exist and that no more competent oocytes can be obtained if it is exceeded [12]. …”
Section: Introductionmentioning
confidence: 99%
“…Recently follitropin delta has been described (FE 999049), the first recombinant FSH protein in clinical development that is expressed in a human cell line (PER.C6), with individualized dosing optimized based on each patient’s weight and anti-Mullerian hormone (AMH) level (10, 11, 12). In female volunteers, follitropin delta displayed distinct pharmacokinetics and pharmacodynamics, with higher exposure and lower serum clearance than follitropin alfa (13).…”
Section: Introductionmentioning
confidence: 99%
“…Despite this, clinicians frequently use large doses of gonadotrophins to try to attain large oocyte yields in excess of 15 oocytes, with the underlying belief that this will improve the overall chances of success. However, large oocyte yields have not been shown to be accompanied by an increase in good-quality blastocysts [11], and RCTs have shown a decrease in fresh embryo transfer associated live-birth rates in women with high oocyte yields [12].…”
Section: Avoid Aggressive Ovarian Stimulationmentioning
confidence: 99%